Image Of Alendronate Sodium Structural Formula (Fosamax Plus D 01)
Fosamax Plus D Tablet
Product Images NDC 78206-137
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fosamax Plus D (NDC 78206-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Of Cholecalciferol Structural Formula (Fosamax Plus D 02)
Image Of Figure 1 (Fosamax Plus D 03)
This text appears to be a graph showing the cumulative incidence over time (in months) for a placebo and FOSAMAX. No further information can be provided without a better context or a clear image of the graph.*
Image Of Figure 2 (Fosamax Plus D 04)
Description: The text is describing a study on the treatment of osteoporosis in postmenopausal women using Fosamax. The study measured the increase in bone mineral density (BMD) in the lumbar spine, femoral neck, and trochanter over the course of three years. The results show a significant increase in BMD compared to the placebo group.*
Image Of Figure 3 (Fosamax Plus D 05)
This is a table showing the mean percentage change from baseline of lumbar spine bone mineral density (BMD) in postmenopausal women with osteoporosis who were treated with FOSAMAX 10 mg/day versus placebo over time. The table also indicates the results of the US multinational study, with FOSAMAX showing a percent change of 10 at 10 months compared to placebo showing a percent change of 4 at 10 months. The SE (standard error) is also provided for each group at different time points.*
Principal Display Panel (70 mg/2800 IU Tablet Blister Pack)
This is a medication label for Fosamax. The label specifies that this medication is dispensed in tablet form and contains 91.37 mg of alendronate sodium (70 mg free acid equivalent) and 70 mcg cholecalciferol, which is equivalent to 2800 1U vitamin D. The medication is intended for adults and should be taken once a week. Additional information, including the manufacturer and dosage information, can be found in the accompanying circular. The label also includes a space reserved for a 2D serialization barcode, serial number, expiry, and lot number.*
Principal Display Panel (70 mg/5600 IU Tablet Blister Pack)
This text is a mix of errors, missing letters, and incomplete sentences. There is mention of FOSAMAX medication guide, dosage information, and prescription label. There is also a mention of a medication containing alendronate sodium and cholecalciferol. However, due to the issues and lack of full sentences, it is difficult to provide a useful description.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
